Correction: Clinical outcomes of combination therapy for hepatocellular carcinoma in a predominantly hispanic South Texas population
Frontiers in Oncology · 20.11.2026 · 16
DOI: 10.3389/fonc.2026.2026517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.11.2026. Verfasst von John Hoverson und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hoverson, J., Qi, J., Mehmken, C., Chiu, D., Lowry, J., Arora, S. P., & Newman, N. (2026). Correction: Clinical outcomes of combination therapy for hepatocellular carcinoma in a predominantly hispanic South Texas population. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.2026517
Vancouver
Hoverson J, Qi J, Mehmken C, Chiu D, Lowry J, Arora SP, et al. Correction: Clinical outcomes of combination therapy for hepatocellular carcinoma in a predominantly hispanic South Texas population. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.2026517
BibTeX
@article{Hoverson2026,
author = {Hoverson, John and Qi, Jonathan and Mehmken, Cameron and Chiu, Darian and Lowry, Jack and Arora, Sukeshi Patel and Newman, Neil},
title = {Correction: Clinical outcomes of combination therapy for hepatocellular carcinoma in a predominantly hispanic South Texas population},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.2026517}
}
EUVIMED